Sibutramine - Kyungdong PharmAlternative Names: Silumin Cap.
Latest Information Update: 27 Jul 2016
At a glance
- Originator Kyungdong Pharm
- Class Anorectics; Cyclobutanes; Obesity therapies
- Mechanism of Action Adrenergic uptake inhibitors; Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Obesity
Most Recent Events
- 27 Jul 2016 Chemical structure information added
- 20 Jul 2016 Investigation in Obesity in South Korea (PO)